Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 4, 1998, Pages 297-301

  Yokoyama, Naoyuki ^a   Hitomi, Jiro ^a   Watanabe, Hidenobu ^a   Ajioka, Yoichi ^a   Pruyas, Martha ^b   Serra, Ivan ^c   Shirai, Yoshio ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; PROTEIN P53;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER INCIDENCE; CHILE; CLINICAL ARTICLE; CPG ISLAND; FEMALE; GALLBLADDER CARCINOMA; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031950070     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Serra, I., Calvo, A., Maturana, M., and Sharp, A. Biliary-tract cancer in Chile Int. J. Cancer, 46: 965-971, 1990.
2. Ministry of Health and Welfare. Vital Statistics of Japan. Tokyo: Health & Welfare Stat Assoc., 1996.
3. Tominaga, S., Kuroishi, T., Ogawa, H., and Shimizu, H. Epidemiologic aspects of biliary tract cancer in Japan Natl. Cancer Inst. Monogr, 53: 25-34, 1979.
4. Kato, K., and Akai, S. Geographical distribution of biliary tract cancer in Niigata prefecture. Jpn J. Clin. Oncol., 20: 67-71, 1990.
5. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
6. Hsu, I C , Metcalf, R A , Sun, T , Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350 427-428, 1991
7. Harris, C. C. The 1995 Walter Hubert Lecture-molecular epidemiology of human cancer insights from the mutational analysis of the p53 tumor-suppressor gene. Br J. Cancer, 73: 261-269, 1996
8. Gao, H., Wang, L D., Zhou, Q., Hong, J. Y., Huang, T. Y., and Yang, C. S. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations, in Henan, China. Cancer Res. 54: 4342-4346, 1994.
9. Lou, A., Tseng, S , Chang, S., Yue, C., Chang, B., Chou, C., Yang, S., Teh, B., Wu, C., and Shen, C. Novel patterns of p53 abnormality in breast cancer from a low-incidence area Br. J. Cancer, 75: 746-751, 1997
10. Oohashi, Y., Watanabe, H , Ajioka, Y., and Hatakeyama, K p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol. Int., 45: 58-65, 1995.
11. Teh, M , Wee, A., and Raju, G. C. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer (Phila.), 74: 1542-1545, 1994
12. Wistuba, I. I., Gazdar, A. F., Roa, I., and Albores, S. J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum. Pathol., 27: 360-365, 1996.
13. Takagi, S., Naito, E., Yamanouchi, H. Ohtsuka, H., Kominami, R., and Yamamoto, M., Mutation of the p53 gene in gallbladder cancer Tohoku J. Exp. Med., 172: 283-289, 1994.
14. Fujii, K., Yokozaki, H., Yasui, W., Kuniyasu, H., Hirata, M., Kajiyama, G., and Tahara, E. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol. Biomark. Prev., 5: 461-466, 1996.
15. General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract, Ed. 3 (in Japanese). Tokyo: Japanese Society of Biliary Surgery, 1993.
16. Keleti, J., Quezado, M. M , Abaza, M. M., Raffeld, M , and Tsokos, M. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein Am. J Pathol., 149: 143-151, 1996
17. Mano, H., Yamamoto, M., Kinebuchi, H., Araki, K , and Ohta, T. Geographical variations in mutagenicity of blue rayon extracts of Japanese human bile. Mutat. Res., 341: 225-234, 1995.
18. Harris, C. C. Deichmann Lecture-p53 tumor suppressor gene: at the cross-roads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicol. Lett., 83: 1-7, 1995.
19. Jones, P. A , Buckley, J. D., Henderson, B. E., Ross, R. K., and Pike, M. C. From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res., 51: 3617-3620, 1991.
20. Rideout, W M., Coetzee, G. A., Olumi, A. F., and Jones, P. A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (Washington DC), 249: 1288-1290, 1990.